We hope you enjoyed the UKI NETS 18th National conference online! The UK and Ireland Neuroendocrine Tumour Society (UKI NETS) […]
Read More about UKINETS Annual Conference – Monday 30th November – Thursday 3rd December
UPDATE: Sadly Nets for Newcomers on 12th February is postponed due to the ongoing COVID pandemic as many speakers and […]
Read More about NETs for Newcomers – An introduction to NET Medicine – POSTPONED
Australasian Gastro-Intestinal Trials Group 23rd Annual Scientific Meeting 12-15 October 2021 Sofitel Melbourne on Collins Convenor: Professor Stephen Ackland asm.gicancer.org.au […]
Read More about AGITG 23rd Annual Scientific Meeting – 12-15 October 2021
NCUK (formerly the NET Patient Foundation) is about to present a weekend-long schedule full of passionate Neuroendocrine Cancer experts, specialists […]
Read More about NCUK Virtual Patient Summit and NET Cancer Day
“We are very aware that there are costs associated with getting to and from hospital appointments, especially for investigations and […]
Read More about NCUK Compassionate Welfare Grant for NET patients
We are pleased to announce the 2020 round of the Neuroendocrine Cancer UK Research Grant in support of NET research. […]
Read More about NCUK Research Grant – call for applications
After many months, and a few hurdles, Neuroendocrine Cancer UK (previously NET Patient Foundation) have officially launched their new rebranded […]
Read More about Neuroendocrine Cancer UK launches new website
The Society for Endocrinology journal, Endocrine-Related Cancer<https://erc.bioscientifica.com/>, has recently published a special issue on ‘Hereditary endocrine tumours: Current state-of-the-art and […]
Read More about ‘Hereditary endocrine tumours’ – special issue of Endocrine-Related Cancer
In times of the Covid-19 crisis, the BNMS have decided to present their annual autumn meeting online. J’We are […]
Read More about BNMS first-ever online meeting – Wednesday 23rd September
UK and Ireland Neuroendocrine Tumour Society- UKINETS COVID-19 pandemic strategy for the interim management of patients with Neuroendocrine Tumours/Neuroendocrine Cancer […]
Read More about COVID-19 pandemic strategy for the interim management of patients with Neuroendocrine Tumours/Neuroendocrine Cancer